Causality of Poisoning of the Elderly: Prospective Study Based on Data From the Poison Control Centre of Bordeaux

Intoxication Clinical Trial

— GERIATOX  

Official title:

Causality of Poisoning of the Elderly: Prospective Study Based on Data From the Poison Control Centre of Bordeaux Over 5 Months

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03726632
• Other study ID #: CHUBX 2017/02
• Status: Completed
• Start date: April 3, 2017
• Est. completion date: August 2, 2017

Study information

• Verified date: October 2018
• Source: University Hospital, Bordeaux
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Elderly is often associated with social, physiological and psychic changes. However, no study has examined accidental poisoning-induced changes.

The objective of the study is to identify and analyze the various causes of potentially toxic accidental exposure of the elderly to determine preventable causes and propose prevention strategies.

Description:

Elderly is often associated with social, physiological and psychic changes. Many studies tried to demonstrate their influence in the genesis of pathological events such as falls or suicide of the elderly but none on the genesis of accidental poisoning.

However, poisoning in this age group is frequent and sometimes severe. In order to improve care of the elderly, it seems necessary to focus on potential toxic accidental exposure.

For this, Poison Control Centre of the University Hospital of Bordeaux has identified the causes over a period of 5 months (from 01 March to 31 July 2017) from calls to the centre.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 122
• Est. completion date: August 2, 2017
• Est. primary completion date: August 2, 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 65 Years and older

Eligibility

Inclusion Criteria:

• All subjects aged 65 and over,

• Victims of accidental exposure regardless of the agent (drug, household product, plant ...)

• Victims of voluntary exposure (out of suicidal behavior)

• And for which a call (notice, report) to the Poison Control Centre of Bordeaux has been recorded.

• Calling dates between March 1st and July 31st, even if the exhibition is prior to March 1st, 2017).

Exclusion Criteria:

• Suicide

• Calls for inquiries

Related Conditions & MeSH terms

• Intoxication
• Poisoning

Locations

Country	Name	City	State
France	Centre Anti Poision du CHU de Bordeaux	Bordeaux

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Bordeaux

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Nature of the agent	The nature of the agent has to be chosen among (1 choice only): drug, chemical, household product, DIY product, phytosanitary product, gas, plant, foreign body, food	Baseline
Secondary	Circumstance of the event	The circumstance of the event has to be chosen among (1 choice only): accidental / voluntary	Baseline
Secondary	Exposition route of exposure	The exposition route of exposure has to be chosen among (1 choice only): ingestion, eyepiece, dermal, inhalation or multiple routes	Baseline
Secondary	symptoms	Number / Nature	Baseline
Secondary	Poisoning Severity	The poisoning severity is evaluated using the Poisoning Severity Scale (PSS score). Severity grades: None (No symptoms or signs related to poisoning); MINOR (Mild, transient and spontaneously resolving symptoms); MODERATE (Pronounced or prolonged symptoms); SEVERE (Severe or life-threatening symptoms); DEATH	Baseline
Secondary	Death	death before the call	Baseline
Secondary	Frailty status	The frailty status is calculated from the following factors: sensory disturbance, cognitive and/or neurological disorder, psychiatric disorder, autonomy / dependence, concomittant treatments	Baseline
Secondary	packaging of the agent	The packaging of the agent has to be chosen among (1 choice only): solid, liquid, gaseous, powder and if drug: tablet, drops, syrup, patch, injectable	Baseline
Secondary	Concomittant treatment	Number of prescription drugs	Baseline